Evidence map›Paper›PMID 40938636›Full record

ReviewJournal of medical microbiology2025

Shaping the future of

Alexandre Giraud-Gatineau, Kouessi Dagbo, Helena Pětrošová, Catherine Werts, Fréderic J Veyrier, Mathieu Picardeau

Abstract readReview
In one paragraph

Review in Journal of medical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. A systematic review and meta-analysis ofOne health (Amsterdam, Netherlands) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Advances in the development of a vaccine for the prevention of human leptospirosis: a review.Revista do Instituto de Medicina Tropical de Sao Paulo · 2026
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexandre Giraud-GatineauBiology of Spirochetes Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Kouessi DagboBacterial Symbionts Evolution, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Université du Québec, Laval, Canada.
Helena PětrošováGenome BC Proteomics Centre, University of Victoria, Victoria, BC, Canada.
Catherine WertsBiology and Genetics of Bacterial Cell Walls unit, Institut Pasteur, Université Paris Cité, Paris, France.
Fréderic J VeyrierBacterial Symbionts Evolution, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Université du Québec, Laval, Canada.
Mathieu PicardeauBiology of Spirochetes Unit, Institut Pasteur, Université Paris Cité, Paris, France.

Funding

Virulence and Adaptation to the Host Environment of Pathogenic LeptospiraP01AI168148 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DAVID A HAAKE · 2023 to 2026
$11.8M
NIAID NIH HHS P01 AI168148
6 · The paper itself

Abstract

Leptospirosis is a re-emerging zoonosis caused by a diverse range of pathogenic

Indexed as

LeptospiraLeptospirosisSerotypingAnimalsHumansO AntigensSerogroupO Antigensdiagnosisepidemiologyleptospirosisserologystrain typing

Identifiers

PMID40938636
PMCPMC12451757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.